Diagnosing and treating type 1 diabetes
JDRF created an initiative that provides at-home tests to check for autoantibodies that are important markers for type 1 diabetes. The test is valued at a regular rate of 55 dollars. People who cannot afford the test can get it at a discount rate of 10 dollars. With these tests, you can take treatment steps before diagnosis. When Teplizumab is released into the market, people who tested positive can start the prevention therapy. JDRF continues to provide sensitization about early diagnosis. In most cases, medical doctors don’t usually know what to do with people who are at a high risk of type 1 diabetes [6]. This is why the invention of Teplizumab is a big deal to everyone in the medical world.
Conclusion
Teplizumab is a revolutionary drug invention that plays a significant role in preventing type 1 diabetes. While it is not yet approved by the FDA, it has proven to be an effective drug for stabilizing the immune system and promoting the production of insulin from beta cells.
References
[1] https://www.healthline.com/health/rashes
[2] https://www.endocrineweb.com/conditions/type-1-diabetes/what-insulin
[3] https://www.nhs.uk/common-health-questions/food-and-diet/what-is-the-glycaemic-index-gi/
[4] https://www.medicalnewstoday.com/articles/320101
[5] https://www.news-medical.net/life-sciences/What-are-Autoantibodies.aspx
[6] https://www.mayoclinic.org/diseases-conditions/type-1-diabetes/symptoms-causes/syc-20353011